Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AUR vs GSK✓SelectedUSD · GSKAUR vs GSK performance historyLatest closeAs of-1.54%11/19
Stock and ETF performance explorer

AUR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-61.6%
GSK return
+56.9%
Excess return
-118.5%
Maximum drawdown
-93.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-1.6%0.0%-1.3%
7D-11.7%-4.7%-7.0%-11.1%
30D-23.4%-4.7%-18.7%-22.8%
3M-38.0%-8.8%-29.3%-37.2%
6M-44.7%-4.6%-40.0%-44.5%
YTD0.0%+1.0%-1.0%-1.2%
1Y+0.3%+6.9%-6.6%-2.1%
3Y+74.5%+52.5%+22.0%+54.2%
5Y-77.6%+40.3%-117.8%-80.1%
All-61.6%+56.9%-118.5%-65.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling